


Pfizer Appeal Targets Fraudulent Drug Marketing Claims Brought Under Civil RICO Statute

Federal Appeals Court Rejects Whistleblower’s Medical Device Defect Claim

Are Name-Brand Drug Makers Liable for Generic Equivalents?

Courts OK Discounted Subsidies for Branded Prescription Drugs

FDA Bars Generic “Copycat” OxyContin: Will Efforts to Limit Abuse of the Painkiller Also Limit Competition?
Blogs
Firm/Org